Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Can you guess the (lightly disputed) champion of healthcare AI suppliers? Here’s a hint. This company caters to physicians and just this week reached a valuation of $12B.
UnitedHealth Group CEO Stephen Hemsley is expected to make the announcement in front of Congress, where he will also offer other policy solutions. The company said it’s still working out details on how to best distribute its profits to customers.
Almost half of U.S. executives working in or close to the C-suite, 44.7%, see AI as the emerging technology most likely to put their internal-control systems at risk over the next 12 months.
Generative AI of the “large language” kind has been an attention hog over the past 10 or 11 months. The buzz has been so loud and constant that it’s all but asking to be dismissed as hype.
Do you know who owns your personal favorite doctor’s practice? Could it be a healthcare conglomerate? An insurance company? A private equity firm? Amazon?
It’s easy to see the appeal of cross-market hospital mergers to the marrying partners. How these long-distance entwinements help patients is a separate question.